Nanomedicine

The aim of this group is to enable nanomedicine players to express the specific needs of their sector, and to consider the actions to be taken to meet the regulatory requirements of the competent authorities (ANSM, EMA, FDA...). The objectives are to identify the gaps in terms of available and recognized testing methods, the framework to be built to facilitate the assessment of laboratory skills, and the actions to be taken to create links with experts and key players in standardization and regulation.

Main actions :

- Information sharing & Event organization,

- Identification of needs in terms of validated and recognized methods to meet regulatory requirements,

- Reflection on the concepts of orthogonal and complementary methods mentioned in FDA guidelines